ANI Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	1,518	1,650	1,079	1,052	656	771
Market Cap Growth	20.58%	52.89%	2.58%	60.42%	-14.98%	121.46%
Enterprise Value	1,935	2,010	1,583	1,175	913	966
Last Close Price	77.15	78.94	55.28	55.14	40.23	46.08
PE Ratio	22.27	21.38	-	68.00	-	-
Forward PE	8.55	10.03	10.72	14.04	14.79	12.86
PS Ratio	1.83	1.87	1.76	2.16	2.07	3.57
PB Ratio	3.19	3.05	2.52	2.30	1.94	2.15
P/TBV Ratio	-	-	-	5.38	19.39	64.94
P/FCF Ratio	9.41	9.63	22.59	9.56	-	1008.43
P/OCF Ratio	8.71	8.91	16.86	8.85	-	232.23
PEG Ratio	-	0.40	0.40	0.40	1.11	1.02
EV/Sales Ratio	2.19	2.28	2.58	2.41	2.89	4.47
EV/EBITDA Ratio	11.21	11.64	19.23	10.75	26.93	50.64
EV/EBIT Ratio	23.82	24.75	108.31	23.73	-	-
EV/FCF Ratio	11.29	11.73	33.14	10.67	-	1263.31
Debt / Equity Ratio	1.14	1.14	1.47	0.62	0.85	0.80
Debt / EBITDA Ratio	3.57	3.57	7.44	2.61	8.26	15.06
Debt / FCF Ratio	3.60	3.60	13.20	2.60	-	375.65
Net Debt / Equity Ratio	0.60	0.60	1.12	0.14	0.71	0.52
Net Debt / EBITDA Ratio	1.87	1.87	5.82	0.59	7.07	9.80
Net Debt / FCF Ratio	1.88	1.88	10.04	0.59	-5.98	244.54
Asset Turnover	0.65	0.65	0.56	0.59	0.41	0.35
Inventory Turnover	2.44	2.44	2.02	1.68	1.48	1.41
Quick Ratio	2.07	2.07	1.93	2.63	2.15	2.61
Current Ratio	2.71	2.71	2.73	3.57	3.46	3.68
Return on Equity (ROE)	16.16%	16.16%	-4.18%	4.72%	-13.74%	-15.37%
Return on Assets (ROA)	3.73%	3.73%	0.83%	3.72%	-2.10%	-2.86%
Return on Invested Capital (ROIC)	7.68%	7.50%	2.04%	8.51%	-4.58%	-6.04%
Return on Capital Employed (ROCE)	7.00%	7.00%	1.30%	6.50%	-3.90%	-4.10%
Earnings Yield	4.79%	4.75%	-1.72%	1.79%	-7.30%	-5.52%
FCF Yield	10.63%	10.39%	4.43%	10.46%	-6.11%	0.10%
Payout Ratio	-	1.48%	-	8.65%	-	-
Buyback Yield / Dilution	-9.89%	-9.89%	-6.18%	-11.89%	-29.09%	-5.28%

Updated Feb 27, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q